Topotecan Completed Phase 1 Trials for Gynecological Malignancies / Malignancies / Tumors, Solid / Carcinoma NOS / Metastases / Cancer of the Ovary / Tumors / Fallopian Tube Cancer / Oncology Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00422682A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors
NCT00770536AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
NCT00250094Clinical Benefit of Topoisomerase Downregulation
NCT01683149Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies
NCT00502892Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
NCT00193570Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
NCT00193583Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors